Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Controlled Clinical Trial
. 2007 Mar;292(3):E812-9.
doi: 10.1152/ajpendo.00300.2006. Epub 2006 Nov 14.

Blunted lipolysis and fatty acid oxidation during moderate exercise in HIV-infected subjects taking HAART

Affiliations
Controlled Clinical Trial

Blunted lipolysis and fatty acid oxidation during moderate exercise in HIV-infected subjects taking HAART

W Todd Cade et al. Am J Physiol Endocrinol Metab. 2007 Mar.

Abstract

The protease inhibitor (PI) ritonavir (RTV) has been associated with elevated resting lipolytic rate, hyperlipidemia, and insulin resistance/glucose intolerance. The purpose of this study was to examine relationships between lipolysis and fatty acid (FA) oxidation during rest, moderate exercise and recovery, and measures of insulin sensitivity/glucose tolerance and fat redistribution in HIV-positive subjects taking RTV (n=12), HAART but no PI (n=10), and HIV-seronegative controls (n=10). Stable isotope tracers [1-(13)C]palmitate and [1,1,2,3,3-(2)H5]glycerol were continuously infused with blood and breath collection during 1-h rest, 70-min submaximal exercise (50% VO2 peak), and 1-h recovery. Body composition was evaluated using DEXA, MRI, and MRS, and 2-h oral glucose tolerance tests with insulin monitoring were used to evaluate glucose tolerance and insulin resistance. Lipolytic and FA oxidation rates were similar during rest and recovery in all groups; however, they were lower during moderate exercise in both HIV-infected groups [glycerol Ra: HIV+RTV 5.1+/-1.2 vs. HIV+no PI 5.9+/-2.8 vs. Control 7.4+/-2.2 micromol.kg fat-free mass (FFM)-1.min-1; palmitate oxidation: HIV+RTV 1.6+/-0.8 vs. HIV+no PI 1.6+/-0.8 vs. Control 2.5+/-1.7 micromol.kg FFM.min, P<0.01]. Fasting and orally-challenged glucose and insulin values were similar among groups. Lipolytic and FA oxidation rates were blunted during moderate exercise in HIV-positive subjects taking HAART. Lower FA oxidation during exercise was primarily due to impaired plasma FA oxidation, with a minor contribution from lower nonplasma FA oxidation. Regional differences in adipose tissue lipolysis during rest and moderate exercise may be important in HIV and warrant further study.

PubMed Disclaimer

Figures

Fig 1
Fig 1
A: glycerol. B: palmitate kinetics. C: palmitate oxidation rate during rest, submaximal exercise, and recovery. D: fatty acid (FA) oxidation rates [plasma (significance denoted above bar) and nonplasma (significance denoted mid-bar)] during exercise in the 3 groups. *P < 0.01; **P < 0.005; $P < 0.05; $$P < 0.07 vs. Control. Ra, rate of appearance; FFM, fat-free mass; FFA, free fatty acid; HIV, human immunodeficiency virus; PI, protease inhibitor; RTV, ritonavir.

Similar articles

Cited by

References

    1. Adler-Wailes DC, Liu H, Ahmad F, Feng N, Londos C, Manganiello V, Yanovski JA. Effects of the human immunodeficiency virus-protease inhibitor, ritonavir, on basal and catecholamine-stimulated lipolysis. J Clin Endocrinol Metab. 2005;90:3251–3261. - PMC - PubMed
    1. American College of Sports Medicine. ACSM’s Guidelines for Exercise Testing and Prescription. Baltimore, MD: Lippincott, Williams & Wilkins; 2000.
    1. Bastard JP, Caron M, Vidal H, Jan V, Auclair M, Vigouroux C, Luboinski J, Laville M, Maachi M, Girard PM, Rozenbaum W, Levan P, Capeau J. Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance. Lancet. 2002;359:1026–1031. - PubMed
    1. Beylot M, Martin C, Beaufrere B, Riou JP, Mornex R. Determination of steady state and nonsteady-state glycerol kinetics in humans using deuterium-labeled tracer. J Lipid Res. 1987;28:414–422. - PubMed
    1. Bottini P, Tantucci C, Scionti L, Dottorini ML, Puxeddu E, Reboldi G, Bolli GB, Casucci G, Santeusanio F, Sorbini CA, Brunetti P. Cardio-vascular response to exercise in diabetic patients: influence of autonomic neuropathy of different severity. Diabetologia. 1995;38:244–250. - PubMed

Publication types